Need professional-grade analysis? Visit stockanalysis.com
$25.22M
N/A
N/A
N/A
India Globalization Capital Inc (IGC) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.34, down 3.22% from the previous close.
Over the past year, IGC has traded between a low of $0.25 and a high of $0.47. The stock has gained 13.2% over this period. It is currently 27.7% below its 52-week high.
India Globalization Capital Inc has a market capitalization of $25.22M.
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Side-by-side comparison against top Healthcare peers.